Elevation Oncology, Inc. - 28623U101

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2025 · Q1 2025
Value (USD)
Total reported value ($000)
$10.84M
QoQ value delta ($000)
+$6.005M (+124.3%)
Implied price effect (QoQ)
+42.18%
Shares
Total shares
29,591,166
QoQ shares delta
+10,833,857 (+57.76%)
Total shares held by funds (by quarter)

Top holders (Q2 2025)

Top 25 only Full list
Early Q3 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Frazier Life Sciences Management, L.P. 2,200 5,993,579 0.09%
BML Capital Management, LLC 2,162 5,890,434 1.64%
Aisling Capital Management LP 1,040 2,834,910 0.29%
VANGUARD GROUP INC 828 2,256,690 0.0%
Opaleye Management Inc. 529 1,442,061 0.11%
DELTEC ASSET MANAGEMENT LLC 527 1,436,363 0.09%
MILLENNIUM MANAGEMENT LLC 522 1,424,446 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 370 1,010,308 0.0%
Rangeley Capital, LLC 332 905,289 0.4%
ExodusPoint Capital Management, LP 219 597,017 0.0%
GEODE CAPITAL MANAGEMENT, LLC 197 538,656 0.0%
CITADEL ADVISORS LLC 148 405,203 0.0%
BlackRock, Inc. 135 369,048 0.0%
DIADEMA PARTNERS LP 133 362,935 0.04%
SPHERA FUNDS MANAGEMENT LTD. 120 328,562 0.03%
GTS SECURITIES LLC 110 300,029 0.0%
AMERIPRISE FINANCIAL INC 108 294,326 0.0%
Palumbo Wealth Management LLC 108 295,328 0.03%
Yakira Capital Management, Inc. 96 263,097 0.03%
TWO SIGMA INVESTMENTS, LP 93 254,295 0.0%
JANE STREET GROUP, LLC 93 255,443 0.0%
GOLDMAN SACHS GROUP INC 82 224,159 0.0%
UBS Group AG 74 201,655 0.0%
STATE STREET CORP 71 194,800 0.0%
PenderFund Capital Management Ltd. 71 195,700 0.02%